Irritable Bowel Syndrome
Study Name: Irritable Bowel Syndrome
Clinics: Barnsley, Blackpool, Cannock, Leeds, Liverpool, Manchester and Teesside.
Therapy Area: Irritable Bowel Syndrome
Gender and Age: Males & Females Aged 18-70
IBS is a common condition of the digestive system that affects around 10-15% of adults. It can cause symptoms like abdominal pain or discomfort, stomach cramps, bloating, diarrhoea and constipation.
This trial will test the effect of Blautix® (the investigational study drug) compared to placebo (inactive pill) on symptoms of irritable bowel syndrome. There will be 5 visits to one of our clinics over approximately 16 weeks. The study drug or placebo is to be taken orally as two capsules, twice daily.
Reimbursement: Up to £150 plus reasonable travel
Key Inclusion Criteria:
Male or female aged 18 – 70 years
Diagnosis of IBS
Abdominal pain at least once a week due to IBS
BMI 18 – 39 kg/m2.
Key Exclusion Criteria:
Diagnosis of lactose intolerance or Coeliac disease
Significant changes to diet in the last 3 months
Other eligibility criteria will apply. Please contact MAC for more information.
Any other information
Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.